Evidence map›Paper›PMID 27507811›Full record

ArticleThe Journal of biological chemistry2016

Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis.

Jiyeon Yu, Hyeongseok Yun, Bongjin Shin, Yongjin Kim, Eui-Soon Park, Seunga Choi, Jungeun Yu, Dulshara Sachini Amarasekara, Sumi Kim, Jun-Ichiro Inoue and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Jiyeon YuFrom the Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 305-764, Korea.
Hyeongseok YunFrom the Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 305-764, Korea.
Bongjin ShinFrom the Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 305-764, Korea.
Yongjin KimFrom the Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 305-764, Korea.
Eui-Soon ParkFrom the Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 305-764, Korea.
Seunga ChoiFrom the Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 305-764, Korea.
Jungeun YuFrom the Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 305-764, Korea.
Dulshara Sachini AmarasekaraFrom the Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 305-764, Korea.
Sumi KimFrom the Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 305-764, Korea.
Jun-Ichiro Inouethe Division of Cellular and Molecular Biology, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
Matthew C Walshthe Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, and.
Yongwon Choithe Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, and.
Masamichi Takamithe Department of Biochemistry, School of Dentistry, Showa University, Shinagawaku, 142-8555, Japan.
Jaerang RhoFrom the Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 305-764, Korea, jrrho@cnu.ac.kr.
Chungnam National University · KRUniversity of Pennsylvania · USShowa University · JPTokyo University of Science · JP

Funding

Cell Adhesion Regulation of Osteoclast MaturationR01AR069546 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI CHOI, YONGWON · 2016 to 2020
$1.8M
Molecular regulation of osteoclast maturationR01AR067726 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI CHOI, YONGWON · 2015 to 2018
$1.4M
NIAMS NIH HHS R01 AR067726NIAMS NIH HHS R01 AR069546
6 · The paper itself

Abstract

The signaling pathway downstream of stimulation of receptor activator of nuclear factor κB (RANK) by RANK ligand is crucial for osteoclastogenesis. RANK recruits TNF receptor-associated factor 6 (TRAF6) to TRAF6-binding sites (T6BSs) in the RANK cytoplasmic tail (RANKcyto) to trigger downstream osteoclastogenic signaling cascades. RANKcyto harbors an additional highly conserved domain (HCR) that also activates crucial signaling during RANK-mediated osteoclastogenesis. However, the functional cross-talk between T6BSs and the HCR in the RANK signaling complex remains unclear. To characterize the cross-talk between T6BSs and the HCR, we screened TRAF6-interacting proteins using a proteomics approach. We identified Vav3 as a novel TRAF6 binding partner and evaluated the functional importance of the TRAF6-Vav3 interaction in the RANK signaling complex. We demonstrated that the coiled-coil domain of TRAF6 interacts directly with the Dbl homology domain of Vav3 to form the RANK signaling complex independent of the TRAF6 ubiquitination pathway. TRAF6 is recruited to the RANKcyto mutant, which lacks T6BSs, via the Vav3 interaction; conversely, Vav3 is recruited to the RANKcyto mutant, which lacks the IVVY motif, via the TRAF6 interaction. Finally, we determined that the TRAF6-Vav3 interaction resulting from cross-talk between T6BSs and the IVVY motif in RANKcyto enhances downstream NF-κB, MAPK, and NFATc1 activation by further strengthening TRAF6 signaling, thereby inducing RANK-mediated osteoclastogenesis. Thus, Vav3 is a novel TRAF6 interaction partner that functions in the activation of cooperative signaling between T6BSs and the IVVY motif in the RANK signaling complex.

Indexed as

Amino Acid MotifsCell LineHumansIntracellular Signaling Peptides and ProteinsMAP Kinase Signaling SystemMultiprotein ComplexesNFATC Transcription FactorsOsteoclastsProto-Oncogene Proteins c-vavReceptor Activator of Nuclear Factor-kappa BTNF Receptor-Associated Factor 6UbiquitinationIntracellular Signaling Peptides and ProteinsMultiprotein ComplexesNFATC1 protein, humanNFATC Transcription FactorsProto-Oncogene Proteins c-vavReceptor Activator of Nuclear Factor-kappa BTifab protein, humanTNF Receptor-Associated Factor 6TNFRSF11A protein, humanVAV3 protein, humanmitogen-activated protein kinase (MAPK)NFAT transcription factorosteoclastosteoporosissignal transduction

Identifiers

PMID27507811
PMCPMC5034056
OpenAlexW2507831686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.